Mukka Proteins DuPont analysis

·FMCG & RetailChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
0.75×0.78×0.81×0.85×
0.76×0.75×0.73×0.94×
7.3%6.8%8.1%6.7%
1.07×1.07×1.00×1.47×
3.07×3.07×2.36×2.30×
13.8%12.9%11.3%18.2%
11.1%11.1%11.1%17.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MUKKA₹24.68

Mukka Proteins Limited

· FMCG & Retail
₹ CrorePeersNARMADAKSEMcap ₹740 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.850.810.780.75
Interest Burden (Pretax/EBIT) ×0.940.730.750.76
EBIT Margin %6.758.086.767.34
Asset Turnover ×1.471.001.071.07
Financial Leverage (Assets/Equity) ×2.302.363.073.07
ROE (5-step product, year-end total equity) %18.2411.2712.9213.75
ROE (owners' profit / average owners' equity) %17.6911.1011.0811.08
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.